Author Zetterberg, Henrik

1 to 20 of 33 Items
  • 2012 Journal Article
    ​ ​Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies​
    Luk, C.; Compta, Y.; Magdalinou, N.; Jose Marti, M.; Hondhamuni, G.; Zetterberg, H. & Blennow, K. et al.​ (2012) 
    Journal of Neurochemistry123(3) pp. 396​-405​.​ DOI: https://doi.org/10.1111/j.1471-4159.2012.07911.x 
    Details  DOI  PMID  PMC  WoS 
  • 2012 Journal Article
    ​ ​Pyroglutamate Amyloid beta (A beta) Aggravates Behavioral Deficits in Transgenic Amyloid Mouse Model for Alzheimer Disease​
    Wittnam, J. L.; Portelius, E.; Zetterberg, H.; Gustavsson, M. K.; Schilling, S.; Koch, B. & Demuth, H.-U. et al.​ (2012) 
    Journal of Biological Chemistry287(11) pp. 8154​-8162​.​ DOI: https://doi.org/10.1074/jbc.M111.308601 
    Details  DOI  PMID  PMC  WoS 
  • 2013 Journal Article | Research Paper
    ​ ​Analysis of amino-terminal variants of amyloid-β peptides by capillary isoelectric focusing immunoassay​
    Haußmann, U.; Jahn, O. ; Linning, P.; Janßen, C.; Liepold, T.; Portelius, E. & Zetterberg, H. et al.​ (2013) 
    Analytical Chemistry85(17) pp. 8142​-8149​.​ DOI: https://doi.org/10.1021/ac401055y 
    Details  DOI  PMID  PMC 
  • 2014 Journal Article
    ​ ​Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid​
    Fritschi, S. K.; Langer, F.; Kaeser, S. A.; Maia, L. F.; Portelius, E.; Pinotsi, D. & Kaminski, C. F. et al.​ (2014) 
    Brain137(11) pp. 2909​-2915​.​ DOI: https://doi.org/10.1093/brain/awu255 
    Details  DOI 
  • 2015 Journal Article
    ​ ​Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia​
    Jansen, W. J.; Ossenkoppele, R.; Knol, D. L.; Tijms, B. M.; Scheltens, P.; Verhey, F. R. J. & Visser, P. J. et al.​ (2015) 
    JAMA313(19) art. 1924​.​ DOI: https://doi.org/10.1001/jama.2015.4668 
    Details  DOI 
  • 2015 Journal Article | 
    ​ ​A practical guide to immunoassay method validation​
    Andreasson, U.; Perret-Liaudet, A.; van Waalwijk van Doorn, L. J. C.; Blennow, K.; Chiasserini, D.; Engelborghs, S. & Fladby, T. et al.​ (2015) 
    Frontiers in Neurology6 art. UNSP 179​.​ DOI: https://doi.org/10.3389/fneur.2015.00179 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Journal Article
    ​ ​Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study​
    Kruse, N.; Persson, S.; Alcolea, D.; Bahl, J. M. C.; Baldeiras, I.; Capello, E. & Chiasserini, D. et al.​ (2015) 
    Neurobiology of Aging36(9) pp. 2587​-2596​.​ DOI: https://doi.org/10.1016/j.neurobiolaging.2015.05.003 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Journal Article | 
    ​ ​The central biobank and virtual biobank of BiOMarKaPD: a resource for studies on neurodegenerative diseases​
    Reijs, B. L. R.; Teunissen, C. E.; Goncharenko, N.; Betsou, F.; Blennow, K.; Baldeiras, I. & Brosseron, F. et al.​ (2015) 
    Frontiers in Neurology6 art. UNSP 216​.​ DOI: https://doi.org/10.3389/fneur.2015.00216 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics​
    Lelental, N.; Brandner, S.; Kofanova, O.; Blennow, K.; Zetterberg, H.; Andreasson, U. & Engelborghs, S. et al.​ (2016) 
    Journal of Alzheimer's Disease52(1) pp. 51​-64​.​ DOI: https://doi.org/10.3233/jad-150883 
    Details  DOI 
  • 2016 Journal Article
    ​ ​Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration​
    Miller, A.-M.; Rutkowska, A.; Bahl, J. M. C.; Herukka, S.-K.; Koel-Simmelink, M. J. A.; Kruse, N. & Mollenhauer, B. et al.​ (2016) 
    Bioanalysis8(21) pp. 2243​-2254​.​ DOI: https://doi.org/10.4155/bio-2016-0114 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Monitoring of 30 marker candidates in early Parkinson disease as progression markers​
    Mollenhauer, B. ; Zimmermann, J.; Sixel-Döring, F.; Focke, N. K. ; Wicke, T.; Ebentheuer, J. & Schaumburg, M. et al.​ (2016) 
    Neurology87(2) pp. 168​-177​.​ DOI: https://doi.org/10.1212/WNL.0000000000002651 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia​
    Abdelnour, C.; van Steenoven, I.; Londos, E.; Blanc, F.; Auestad, B.; Kramberger, M. G. & Zetterberg, H. et al.​ (2016) 
    Movement Disorders31(8) pp. 1203​-1208​.​ DOI: https://doi.org/10.1002/mds.26668 
    Details  DOI  PMID  PMC  WoS 
  • 2017 Journal Article
    ​ ​A user's guide for α-synuclein biomarker studies in biological fluids: ​Perianalytical considerations​
    Mollenhauer, B. ; Batrla, R.; El-Agnaf, O.; Galasko, D. R; Lashuel, H.; Merchant, K. & Shaw, L. M et al.​ (2017) 
    Movement Disorders32(8) pp. 1117​-1130​.​ DOI: https://doi.org/10.1002/mds.27090 
    Details  DOI  PMID  PMC 
  • 2018 Journal Article
    ​ ​Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study​
    Kranaster, L.; Hoyer, C.; Aksay, S.; Bumb, J.; Müller, N.; Zill, P. & Schwarz, M. et al.​ (2018) 
    Neuropsychobiology77(1) pp. 13​-22​.​ DOI: https://doi.org/10.1159/000491401 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry​
    Lewczuk, P. ; Riederer, P.; O’Bryant, S. E.; Verbeek, M. M.; Dubois, B.; Visser, P. J. & Jellinger, K. A. et al.​ (2018) 
    The World Journal of Biological Psychiatry19(4) pp. 244​-328​.​ DOI: https://doi.org/10.1080/15622975.2017.1375556 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease​
    Mattsson, N.; Groot, C.; Jansen, W. J.; Landau, S. M.; Villemagne, V. L.; Engelborghs, S. & Mintun, M. M. et al.​ (2018) 
    Alzheimer's & Dementia14(7) pp. 913​-924​.​ DOI: https://doi.org/10.1016/j.jalz.2018.02.009 
    Details  DOI 
  • 2018 Journal Article | 
    ​ ​The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease​
    Murray, C. E; Gami-Patel, P.; Gkanatsiou, E.; Brinkmalm, G.; Portelius, E.; Wirths, O.   & Heywood, W. et al.​ (2018) 
    Acta Neuropathologica Communications6(1) art. 62​.​ DOI: https://doi.org/10.1186/s40478-018-0563-8 
    Details  DOI 
  • 2018 Journal Article | 
    ​ ​White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation​
    Teunissen, C. E.; Otto, M. ; Engelborghs, S.; Herukka, S.-K.; Lehmann, S.; Lewczuk, P.   & Lleó, A. et al.​ (2018) 
    Alzheimer's Research & Therapy10(1).​ DOI: https://doi.org/10.1186/s13195-018-0359-x 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia​
    Jansen, W. J.; Ossenkoppele, R.; Tijms, B. M.; Fagan, A. M.; Hansson, O.; Klunk, W. E. & van der Flier, W. M. et al.​ (2018) 
    JAMA Psychiatry75(1) pp. 84​.​ DOI: https://doi.org/10.1001/jamapsychiatry.2017.3391 
    Details  DOI 
  • 2018 Journal Article | 
    ​ ​Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease​
    Kruse, N.; Heslegrave, A.; Gupta, V.; Foiani, M.; Villar-Piqué, A.; Schmitz, M. & Lehmann, S. et al.​ (2018) 
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring10 pp. 461​-470​.​ DOI: https://doi.org/10.1016/j.dadm.2018.06.005 
    Details  DOI  PMID  PMC 

Researcher

Sort

issue date

ASC DESC

Items per Page